By Chuck Bolotin, Next Avenue Contributor
I’m seeing a yearning of many people around my age to return to a simpler time, like when we were growing up. My evidence: the hundreds of interviews I’ve done for Best Places in the World to Retire and the studies we did in which we asked expats about their lives abroad.
Interestingly, many Americans and Canadians have not only moved abroad partly to search for a life reminiscent of an earlier time, but quite a few tell me that they’ve found it — and in some very unlikely places, including Mexico, Panama, Belize and Nicaragua.
Here’s what they told us:
Less Government Involvement
It may sound odd that the government in countries considered to be socialist would have less government involvement than in the U.S., but in the day-to-day lives of the locals, it’s true. Whether these governments would want to be more involved or not, they simply don’t have the resources to do so. That means locals find themselves doing some things that the federal and state governments often do in the United States.
bonds investment: Peugeot S.A. (PUGOY)
- [By SEEKINGALPHA.COM]
Yes, you read that correct! General Motors (NYSE: GM) will probably not settle for just a new 52-week high and will aim to take out the 2013 peak of $41.85. With talks about the Opel sellout to PSA Group (OTCPK:PEUGF) (OTCPK:PUGOY) progressing at a rate much faster than I had anticipated, a (likely) deal announcement on Monday will pave the way for new all-time highs.
- [By John Rosevear]
It’s official: General Motors (NYSE:GM) will sell its long-troubled Opel subsidiary to French automaker Peugeot S.A. (NASDAQOTH:PUGOY) for about $2.3 billion, in a deal expected to close later this year.
- [By Adam Levine-Weinberg]
Now, the General is thinking about ditching Europe for good by selling its European operations to French automaker Peugeot (NASDAQOTH:PUGOY). As long as Peugeot is willing to pay a reasonable price, selling Opel is GM’s best course of action.
bonds investment: Rigel Pharmaceuticals Inc.(RIGL)
- [By Lisa Levin]
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) shares dropped 22 percent to $2.52 after the company reported results from the second FIT Phase 3 study for fostamatinib. The company disclosed that the study did not meet primary endpoint.
bonds investment: YPF Sociedad Anonima(YPF)
- [By WWW.GURUFOCUS.COM]
For the details of Knighthead Capital Management, LLC’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Knighthead+Capital+Management%2C+LLC
These are the top 5 holdings of Knighthead Capital Management, LLCSPDR S&P 500 (SPY) – 1,500,000 shares, 57.03% of the total portfolio. Spirit Realty Capital Inc (SRC) – 9,113,000 shares, 11.82% of the total portfolio. New PositionYPF SA (YPF) – 2,153,795 shares, 7.26% of the total portfolio. Shares reduced by 1.5%TerraForm Global Inc (GLBL) – 9,200,000 shares, 6.61% of the total portfolio. EQT Corp (EQT) – 597,300 shares, 5.9% of the total p
bonds investment: Nabors Industries Ltd.(NBR)
- [By Wayne Duggan]
While Loop maintains a Buy rating on all of the stocks mentioned above, Guggenheim analyst Michael LaMotte isn’t quite so bullish on the sector. Earlier this week, LaMotte downgraded the following oil services stocks from Buy to Neutral:
Baker Hughes Incorporated (NYSE: BHI)
Fairmount Santrol Holdings Inc (NYSE: FMSA)
Helmerich & Payne, Inc. (NYSE: HP)
Nabors Industries Ltd. (NYSE: NBR)
Schlumberger Limited. (NYSE: SLB)
Superior Energy Services
Guggenheim also cut its 2017 oil price forecast from $55 to $48/bbl.
- [By Craig Jones]
On CNBC's "Fast Money Halftime Report", Jon Najarian spoke about Nabors Industries Ltd. (NYSE: NBR). He said that somebody bought 6,500 contracts of the July 11 calls for $0.50 in the first half of the session. The trade breaks even at $11.50 or 16.28 percent above the current market price. Jon Najarian has a long position in the name and he is planning to hold it for a month.
- [By Craig Jones]
Pete Najarian was watching Nabors Industries Ltd. (NYSE: NBR). He said that the stock has been trading in a range between $8 and $18 over the last 52 weeks and although it spiked 2.82 percent on Wednesday, it's still close to the lower end of the range. Anticipating a move higher, traders were buying the June 11 calls for $0.30. Around 6,000 contracts were bought in the first half of the session. The trade breaks even at $11.30 or 10.78 percent above the current market price. Pete Najarian decided to buy the calls and he is going to hold them for 4-5 weeks.
- [By Ben Levisohn]
Last night, Weatherford International (WFT) reported a smaller than expected loss and announcing an alliance with Nabors Industries (NBR)–and the news was celebrated by the market.
- [By Jon C. Ogg]
Nabors Industries Ltd. (NYSE: NBR) rose by 22.3% to $16.11 on Wednesday. Its volume of 17.4 million shares was about 2.5 times normal trading volume. Nabors has a consensus analyst price target of $15.04 and a 52-week trading range of $4.93 to $16.50. The company has a total market cap of $4.6 billion.
bonds investment: Profire Energy, Inc.(PFIE)
- [By Monica Gerson]
Profire Energy, Inc. (NASDAQ: PFIE) is estimated to post its quarterly earnings at $0.00 per share on revenue of $6.74 million.
Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets
bonds investment: Nabriva Therapeutics AG(NBRV)
- [By Lisa Levin]
Shares of Nabriva Therapeutics plc (NASDAQ: NBRV) got a boost, shooting up 10 percent to $9.71. Nabriva Therapeutics announced a $80 million common stock offering.
- [By Lisa Levin]
Nabriva Therapeutics plc (NASDAQ: NBRV) shares shot up 37 percent to $9.38 after the company disclosed that its Phase 3 trial evaluating IV and oral lefamulin met all primary FDA and EMA endpoints.